心力衰竭中的遗传生物标志物:从基因面板到多基因风险评分
Marta Figueiral1,2, Alessia Paldino1,3, Luca Fazzini1,4
1Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, 55905, USA.
Current heart failure reports
|October 15, 2024
概括
遗传生物标志物正在彻底改变心力衰竭 (HF) 护理. 识别基因标记物有助于早期诊断,预后预测和个性化治疗策略,以获得更好的患者结果.
科学领域:
- 心脏病学 心脏病学
- 遗传学 是一个遗传学.
- 个性化医疗是个性化的医疗.
背景情况:
- 全球心力衰竭 (HF) 的患病率正在上升.
- 像人工智能和基因测试这样的先进诊断技术正在改变HF管理.
- 了解HF病因对于改善患者的治疗结果至关重要.
研究的目的:
- 审查与心力衰竭 (HF) 和心肌病相关的遗传标记.
- 突出基因生物标志物在HF诊断,预后和个性化医学中的作用.
- 确定HF个性化治疗方法的目标.
主要方法:
- 关于高频基因标记物的当前文献的综述.
- 分析遗传生物标志物 (SNP,罕见变异) 在HF诊断和管理中的实用性.
- 将遗传洞察与人工智能和心脏成像等先进的诊断工具相结合.
主要成果:
- 遗传生物标志物对于诊断HF基质和预测预后至关重要.
- 基因检测有助于识别临床前HF阶段,并指导个性化治疗.
- 单基因和多基因因素都对HF的遗传异质性有所贡献.
结论:
- 遗传洞察力对于优化HF管理和实现个性化治疗至关重要.
- 基因检测的整合代表了心脏病学中向个性化医学的转变.
- 遗传生物标志物为早期HF检测和量身定制的治疗策略提供了一个有希望的途径.
相关概念视频
Genome-wide Association Studies-GWAS
13.1K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.1K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
61
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
61
Heart Failure II: Pathophysiology
3
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
3
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Polygenic Traits
65.5K
When more than one gene is responsible for a given phenotype, the trait is considered polygenic. Human height is a polygenic trait. Studies have uncovered hundreds of loci that influence height, and there are believed to be many more. Due to the high number of genes involved, as well as environmental and nutritional factors, height varies significantly within a given population. The distribution of height forms a bell-shaped curve, with relatively few individuals in the population at the...
65.5K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
1
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
1


